651.0000 7.25 (1.13%)
NSE Dec 31, 2025 15:31 PM
Volume: 218.5K
 

651.00
1.13%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd.'s price crossed above 100Day SMA today
More from Syngene International Ltd.
Recommended